Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Edgewise Therapeutics Inc’s stock clocked out at $23.32, up 1.48% from its previous closing price of $22.98. In other words, the price has increased by $1.48 from its previous closing price. On the day, 1.33 million shares were traded. EWTX stock price reached its highest trading level at $23.48 during the session, while it also had its lowest trading level at $22.51.
Ratios:
To gain a deeper understanding of EWTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 26.51 and its Current Ratio is at 26.51. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on September 25, 2025, initiated with a Neutral rating and assigned the stock a target price of $20.
On July 30, 2025, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $46.
On June 30, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $42.H.C. Wainwright initiated its Buy rating on June 30, 2025, with a $42 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 17 ’25 when ROBERT MICHAEL CARRUTHERS bought 70,000 shares for $22.38 per share.
Russell Alan J sold 100,000 shares of EWTX for $2,112,450 on Nov 12 ’25. The Chief Scientific Officer now owns 23,400 shares after completing the transaction at $21.12 per share. On Nov 11 ’25, another insider, Fox Jonathan C, who serves as the Director of the company, bought 10,700 shares for $18.64 each. As a result, the insider paid 199,403 and bolstered with 23,702 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EWTX now has a Market Capitalization of 2468851712 and an Enterprise Value of 1909692928.
Stock Price History:
The Beta on a monthly basis for EWTX is 0.28, which has changed by -0.27209377 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, EWTX has reached a high of $35.50, while it has fallen to a 52-week low of $10.60. The 50-Day Moving Average of the stock is 27.69%, while the 200-Day Moving Average is calculated to be 38.37%.
Shares Statistics:
It appears that EWTX traded 1.04M shares on average per day over the past three months and 1124710 shares per day over the past ten days. A total of 105.76M shares are outstanding, with a floating share count of 76.32M. Insiders hold about 27.91% of the company’s shares, while institutions hold 79.03% stake in the company. Shares short for EWTX as of 1763078400 were 10045672 with a Short Ratio of 9.68, compared to 1760486400 on 8616447. Therefore, it implies a Short% of Shares Outstanding of 10045672 and a Short% of Float of 11.129999999999999.
Earnings Estimates
Current recommendations for the stock of the company come from 11.0 analysts. The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.39 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.56 and -$1.66 for the fiscal current year, implying an average EPS of -$1.6. EPS for the following year is -$1.98, with 10.0 analysts recommending between -$1.5 and -$2.34.
